Lie Ma

510 total citations
20 papers, 319 citations indexed

About

Lie Ma is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lie Ma has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Lie Ma's work include CAR-T cell therapy research (5 papers), MicroRNA in disease regulation (3 papers) and Pluripotent Stem Cells Research (2 papers). Lie Ma is often cited by papers focused on CAR-T cell therapy research (5 papers), MicroRNA in disease regulation (3 papers) and Pluripotent Stem Cells Research (2 papers). Lie Ma collaborates with scholars based in China, United States and New Zealand. Lie Ma's co-authors include Yuting Guan, Dali Li, Mingyao Liu, Liren Wang, Honghui Han, Yuting Chen, Zhenliang Sun, Yanlin Ma, Yanhong Yu and Lijuan Wu and has published in prestigious journals such as PLoS ONE, Stem Cells and Molecular Therapy.

In The Last Decade

Lie Ma

18 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lie Ma China 9 235 93 85 45 27 20 319
Meng Lou China 13 328 1.4× 32 0.3× 99 1.2× 93 2.1× 11 0.4× 21 457
Tuan M. Nguyen United States 10 417 1.8× 34 0.4× 72 0.8× 109 2.4× 9 0.3× 14 500
Lupin Jiang China 8 195 0.8× 95 1.0× 80 0.9× 83 1.8× 4 0.1× 12 352
Verónica Rendo Sweden 8 315 1.3× 73 0.8× 76 0.9× 60 1.3× 16 0.6× 16 382
Chenqiang Jia China 7 252 1.1× 47 0.5× 51 0.6× 22 0.5× 27 1.0× 9 301
Michael J. Bradaric United States 11 228 1.0× 38 0.4× 124 1.5× 119 2.6× 16 488
Sasha Pantel United States 4 303 1.3× 82 0.9× 65 0.8× 29 0.6× 16 0.6× 4 336
Tai-Shan Cheng Taiwan 13 258 1.1× 27 0.3× 65 0.8× 53 1.2× 14 383
Marie C. Chia Canada 11 232 1.0× 92 1.0× 112 1.3× 54 1.2× 15 405
Philippos Peidis Canada 10 289 1.2× 31 0.3× 44 0.5× 44 1.0× 14 402

Countries citing papers authored by Lie Ma

Since Specialization
Citations

This map shows the geographic impact of Lie Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lie Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lie Ma more than expected).

Fields of papers citing papers by Lie Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lie Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lie Ma. The network helps show where Lie Ma may publish in the future.

Co-authorship network of co-authors of Lie Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Lie Ma. A scholar is included among the top collaborators of Lie Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lie Ma. Lie Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Lina, Yunfeng Yu, Lie Ma, & Rong Yu. (2025). Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutics. Molecules and Cells. 48(6). 100216–100216. 2 indexed citations
2.
Ma, Lie, Jordan N. Fink, Yao Ke, et al.. (2025). Immunoregulatory iPSC-derived non-lymphoid progeny in autoimmunity and GVHD alloimmunity. Stem Cells. 43(4).
4.
Yu, Han, Lie Ma, Xiaolei Zhang, et al.. (2025). PRMT1/PRMT5-Mediated Differential Arginine Methylation of CRIP1 Promotes the Recurrence of Small Cell Lung Cancer after Chemotherapy. International Journal of Biological Sciences. 21(13). 5956–5974. 1 indexed citations
5.
Cao, Fangfang, et al.. (2024). Bacteria-based bioactive materials for tumor immunotherapy. 1(2). 100013–100013. 1 indexed citations
6.
Ma, Lie, et al.. (2023). Engineering enhanced chimeric antigen receptor-T cell therapy for solid tumors. Immuno-Oncology Technology. 19. 100385–100385. 7 indexed citations
7.
Ma, Lie, Xiangxiang Liu, Yu Han, et al.. (2023). Inhibition of EZH2 alleviates SAHA-induced senescence-associated secretion phenotype in small cell lung cancer cells. Cell Death Discovery. 9(1). 289–289. 11 indexed citations
8.
Ma, Lie, et al.. (2021). MicroRNA expression profile in Lampetra morii upon Vibrio anguillarum infection and miR-4561 characterization targeting lip. Communications Biology. 4(1). 995–995. 3 indexed citations
9.
Yin, Shuming, Lie Ma, Tingting Shao, et al.. (2020). Enhanced genome editing to ameliorate a genetic metabolic liver disease through co-delivery of adeno-associated virus receptor. Science China Life Sciences. 65(4). 718–730. 19 indexed citations
10.
11.
Gou, Meng, Lie Ma, Jiali Lu, et al.. (2019). Comparative transcriptomic analysis provides insights into immune responses of lamprey larvae under three pathogens infections. Molecular Immunology. 117. 147–154. 8 indexed citations
12.
Lin, Jiahao, Lie Ma, Di Zhang, et al.. (2019). Tumour biomarkers—Tracing the molecular function and clinical implication. Cell Proliferation. 52(3). e12589–e12589. 30 indexed citations
13.
Qian, Liren, Dan Li, Lie Ma, et al.. (2016). The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing. Cellular Immunology. 304-305. 49–54. 26 indexed citations
14.
Guan, Yuting, Yanlin Ma, Qi Li, et al.. (2016). CRISPR /Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse. EMBO Molecular Medicine. 8(5). 477–488. 131 indexed citations
15.
Ma, Wei, Lie Ma, Cihang Bao, et al.. (2014). Detection of Esophageal Squamous Cell Carcinoma by Cathepsin B Activity in Nude Mice. PLoS ONE. 9(3). e92351–e92351. 9 indexed citations
16.
Yao, Zhenzhen, Peiyuan Yin, Zhijun Peng, et al.. (2011). Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Molecular BioSystems. 7(9). 2608–2614. 40 indexed citations
17.
Mátrai, Janka, Alessio Cantore, Cynthia C. Bartholomae, et al.. (2010). Integration-defective lentiviral vectors for hemophilia: a safer platform for immune tolerance inducation and reduced genotoxicity. Molecular Therapy. 1 indexed citations
18.
Gao, Jun, Feng Zhu, Zhao‐Shen Li, et al.. (2010). Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets. Diagnostic Cytopathology. 39(12). 875–881. 16 indexed citations
19.
Zhang, Xuejun, Yanhua Liang, Lie Ma, et al.. (2008). Genetic diagnosis in a Chinese Hailey–Hailey disease pedigree with novel ATP2C1 gene mutation. Archives of Dermatological Research. 300(4). 203–207. 10 indexed citations
20.
Li, Minghui, et al.. (2004). [Difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia].. PubMed. 18(2). 137–41. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026